IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN MUTANT QM IL-2), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN
Cancer of Head and Neck
Hoffmann-La Rochemonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
142 Active assets in the Cancer of Head and Neck cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Instituto Nacional de Cancer, Brazil | Phase 4 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II ImmunityBio, Inc. | Phase 3 | BB |
LIDOCAINE Instituto Nacional de Cancer, Brazil | Phase 3 | BB |
Carboplatin Rapa Therapeutics LLC | Phase 3 | BB |
Cyclophosphamide Zelluna Immunotherapy AS | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER) FUSION PROTEIN WITH INTERLEUKIN 2 (HUMAN MUTANT QM IL-2), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SEPRASE) (HUMAN MONOCLONAL FAP-IL-2V HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL FAP-IL-2V LIGHT CHAIN is also rated in:
Advanced/Metastatic Head and Neck, Oesophageal and Cervical CancersDormant
CCC
Indicative ·
53 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →